The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Open accessAbstract
Oxidative stress has been implicated in the pathogenesis of diverse disease states, and may be a common pathogenic mechanism underlying many major psychiatric disorders, as the brain has comparatively greater vulnerability to oxidative damage. This review aims to examine the current evidence for the role of oxidative stress in psychiatric disorders, and its academic and clinical implications. A literature search was conducted using the Medline, Pubmed, PsycINFO, CINAHL PLUS, BIOSIS Preview, and Cochrane databases, with a time-frame extending to September 2007. The broadest data for oxidative stress mechanisms have been derived from studies conducted in schizophrenia, where evidence is available from different areas of oxidative research, including oxidative marker assays, psychopharmacology studies, and clinical trials of antioxidants. For bipolar disorder and depression, a solid foundation for oxidative stress hypotheses has been provided by biochemical, genetic, pharmacological, preclinical therapeutic studies and one clinical trial. Oxidative pathophysiology in anxiety disorders is strongly supported by animal models, and also by human biochemical data. Pilot studies have suggested efficacy of N-acetylcysteine in cocaine dependence, while early evidence is accumulating for oxidative mechanisms in autism and attention deficit hyperactivity disorder. In conclusion, multi-dimensional data support the role of oxidative stress in diverse psychiatric disorders. These data not only suggest that oxidative mechanisms may form unifying common pathogenic pathways in psychiatric disorders, but also introduce new targets for the development of therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This model is consistent with the idea that stress related to psychopathology is associated with physiological and cellular alterations related to telomere length, such as elevated oxidative stress or inflammation.25”
From Telomere Length and Psychopathology: Specificity and Direction of Effects Within the Bucharest Early Intervention Project (2020) · cites this paper as [25]
In the citing paper
“Oxidative stress in psychiatric disorders could result from the overproduction of ROS, impairments in Keap1-Nrf2 signalling, or both due to causes related to psychological stress, physiological impairments, inflammation, and genetic polymorphisms of antioxidant enzymes that are beyond the scope of this review [126,127].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [126]
In the citing paper
“Importantly, antioxidants have shown promising therapeutic benefits in the treatment of psychiatric disorders and are subject to further investigation [126,127,140].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [126]
In the citing paper
“bipolar disorder (BD) [10–14]”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [13]
In the citing paper
“Coming back to NAC, which is a precursor of glutathione, it has been shown that it can significantly improve the standard therapy, as a double-blind randomized placebo-controlled clinical study performed by Ng et al. in 2008 demonstrated [13].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,703
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Oxidative stress: oxidants and antioxidants
Sies, H. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004024 · Cited by 4,577
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · cited 1×
“In a similar vein, oxidation biology is emerging as a promising avenue of investigation, and has been actively pursued in other areas of medicine (Barnham et al., 2004; Mehta et al., 2006; Tsukahara, 2007).”
BackgroundSelf-citationOxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Vitamin E, antioxidant and nothing more
Traber, M. G., & Atkinson, J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.024 · Cited by 1,547
Untreated Depression and Hippocampal Volume Loss
Sheline, Y. I., Gado, M. H., & Kraemer, H. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1516 · Cited by 1,180
Oxidative stress: the paradox of aerobic life
Davies, K. J. A. (1995) · Biochemical Society Symposia · doi:10.1042/bss0610001 · Cited by 1,150
Research works printed but not linked: 9
- Li, 2006, Journal of Zhejiang University. Science B, 7, 1981
- 10.1002/(SICI)1099-0801(199809/10)12:53.0.CO;2-# · DOI
- Frey, 2006, Journal of Psychiatry and Neurosciences, 31, 326
- Zhou, 2007, Biological Psychiatry, none, none
- Zhou, 1999, Chinese Medical Journal, 112, 1093
- Berk, 2007, Bipolar Disorders, 9, 3
- Ben Othmen, 2007, Progress in Neuropsychopharmacology and Biological Psychiatry, none, none
- Young, 2007, Journal of Psychiatry and Neurosciences, 32, 160
- Baker, 2007, Neuropsychopharmacology, none, none
Cited by
Sorted by citations
Items 401–500 of 1,000
Duffy, S. L., Lagopoulos, J., Cockayne, N. L., Lewis, S. J. G., Hickie, I. B., Hermens, D. F., & Naismith, S. L. (2015) · Nutrition · doi:10.1016/j.nut.2015.04.019 · Cited by 38
Animal models of obsessive compulsive disorder: recent findings and future directions
Hoffman, K. L. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.577772 · Cited by 39
Nabavi, S. M., Nabavi, S. F., Sureda, A., Caprioli, G., Iannarelli, R., Sokeng, A. J. T., Braidy, N., Khanjani, S., Moghaddam, A. H., Atanasov, A. G., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.073 · Cited by 37
Lopes, I. S., Oliveira, I. C. M., Capibaribe, V. C. C., Valentim, J. T., da Silva, D. M. A., de Souza, A. G., de Araújo, M. A., Chaves, R. D. C., Gutierrez, S. J. C., Barbosa‐Filho, J. M., et al. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.07.007 · Cited by 40
Zheng, Q., Zhu, T., Hu, H. Z., Zhao, Y., Ying, Y., Luo, X., Ling, Y., Chen, Z., Ji, H., & Jiang, P. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.11.018 · Cited by 37
Beyond the Mind—Serum Trace Element Levels in Schizophrenic Patients: A Systematic Review
Baj, J., Forma, A., Sitarz, R., Karakuła, K. H., Flieger, W., Sitarz, M., Grochowski, C., Maciejewski, R., & Karakuła‐Juchnowicz, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249566 · Cited by 40
Evidence of altered DNA integrity in the brain regions of suicidal victims of Bipolar Depression
Rao, T. S., Mustak, M. S., Hegde, M. L., Dinesh, A., Britton, G. B., Berrocal, R., Rao, K., Shamasundar, N., & Rao, K. S. J. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.70974 · Cited by 37
Thioredoxin: A novel, independent diagnosis marker in children with autism
Zhang, Q.-B., Gao, S., & Zhao, H. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.11.007 · Cited by 37
Assessing oxidative pathway genes as risk factors for bipolar disorder
Fullerton, J. M., Tiwari, Y., Agahi, G., Heath, A., Berk, M., Mitchell, P. B., & Schofield, P. R. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00834.x · Cited by 37
Self-citationAccelerated aging in major depression: the role of nitro-oxidative stress
Luca, M., Luca, A., & Calandra, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/230797 · Cited by 37
Mitochondrial dynamics and psychiatric disorders: The missing link
Papageorgiou, M. P., & Filiou, M. D. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105837 · Cited by 39
Ferlemi, A.-V., Avgoustatos, D., Kokkosis, A. G., Protonotarios, V., Constantinou, C., & Margarity, M. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.04.033 · Cited by 36
Michalakeas, C. A., Parissis, J., Douzenis, A., Nikolaou, M., Varounis, C., Andreadou, I., Antonellos, N., Markantonis-Kiroudis, S., PARASKEVAIDIS, I. A., Ikonomidis, I., et al. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.05.004 · Cited by 36
Oxidative pathways as a drug target for the treatment of autism
Villagonzalo, K.-A., Dodd, S., Dean, O. M., Gray, K. M., Tonge, B. J., & Berk, M. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.528394 · Cited by 36
Self-citationAltun, H., Şahın, N., Kurutaş, E. B., Karaaslan, U., Sevgen, F. H., & Fındıklı, E. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1470360 · Cited by 36
Role of NAD + , Oxidative Stress, and Tryptophan Metabolism in Autism Spectrum Disorders
Essa, M. M., Subash, S., Braidy, N., Al‐Adawi, S., Lim, C. K., Manivasagam, T., & Guillemin, G. J. (2013) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s11355 · Cited by 41
Möller, M., du Preez, J. L., Emsley, R. A., & Harvey, B. H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.021 · Cited by 36
Antidepressant-like effect of the saponins part of ethanol extract from SHF
Liang, Y., Xu, Y., Zhang, X., Duan, H., Jin, M., Sun, Y., Yuan, H., Li, J., Qi, Y., & Qiao, W. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.06.044 · Cited by 35
Maciel, A. L., Abelaira, H. M., de Moura, A. B., de Souza, T. G., Rosa, T., Matos, D., Tuon, T., Garbossa, L., Strassi, A. P., Fileti, M. E., et al. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.12.005 · Cited by 36
Lee, H., Kang, J. M., Myung, W., Choi, J., Lee, C., Na, D. L., Kim, S. Y., Lee, J., Han, S., Choi, S. H., et al. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.02.447 · Cited by 35
RetractedGórny, M., Bilska‐Wilkosz, A., Iciek, M., Hereta, M., Kamińska, K., Kamińska, A., Chwatko, G., Rogóż, Z., & Lorenc‐Koci, E. (2020) · Antioxidants · doi:10.3390/antiox9060538 · Cited by 35
Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine
Matveychuk, D., MacKenzie, E. M., Kumpula, D. J., Song, M.-S., Holt, A., Kar, S., Todd, K. G., Wood, P. L., & Baker, G. B. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01078-3 · Cited by 37
Shupler, M. S., Baame, M., Nix, E., Tawiah, T. A. S., Lorenzetti, F., Saah, J., de Cuevas, R. A., Sang, E., Puzzolo, E., Mangeni, J. N., et al. (2022) · SSM - Mental Health · doi:10.1016/j.ssmmh.2022.100103 · Cited by 38
Nawwar, D. A., Zaki, H. F., & Sayed, R. H. (2021) · Inflammopharmacology · doi:10.1007/s10787-022-01031-w · Cited by 40
Lukić, I., Mitić, M., Djordjevic, J., Tatalović, N., Bozovic, N., Soldatović, I., Mihaljevic, M. M., Pavlović, Z., Radojcic, M. B., Marić, N. P., et al. (2014) · Neuropsychobiology · doi:10.1159/000362841 · Cited by 37
Kato, T. A., & Kanba, S. (2013) · Frontiers in Psychology · doi:10.3389/fnhum.2013.00013 · Cited by 39
Mokoena, M. L., Harvey, B. H., Oliver, D. W., & Brink, C. B. (2010) · Metabolic Brain Disease · doi:10.1007/s11011-010-9189-7 · Cited by 35
Lindqvist, D., Mueller, S., Mellon, S. H., Su, Y., Epel, E. S., Reus, V. I., Rosser, R., Mahan, L., Mackin, R. S., Yang, T. T., et al. (2014) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2014.09.002 · Cited by 33
Psychiatric research: psychoproteomics, degradomics and systems biology
Kobeissy, F. H., Sadasivan, S., Liu, J., Gold, M. S., & Wang, K. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.2.293 · Cited by 34
Fibromyalgia and Bipolar Disorder: Emerging Epidemiological Associations and Shared Pathophysiology
Bortolato, B., Berk, M., Maes, M. H. J., McIntyre, R. S., & Carvalho, A. F. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160126144027 · Cited by 34
Self-citationCamkurt, M. A., Fındıklı, E., Bakacak, M., Tolun, F. İ., & Karaaslan, M. F. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.1.35 · Cited by 31
Monte, A. S., da Silva, F. E. R., Lima, C. N. D. C., Vasconcelos, G. S., Gomes, N. S., Miyajima, F., Vasconcelos, S. M. M., Gama, C. S., Seeman, M. V., de Lucena, D. F., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119875979 · Cited by 35
Abdelzaher, W. Y., Mohammed, H. H., Welson, N. N., Batiha, G. E., Baty, R. S., & Abdel‐Aziz, A. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.715354 · Cited by 35
Ahmadvand, A., Sepehrmanesh, Z., Shahzeidi, A., Mansournia, M. A., & Ghaderi, A. (2021) · International Archives of Health Sciences · doi:10.4103/iahs.iahs_112_20 · Cited by 31
Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder
Nakhal, M. M., Aburuz, S., Sadek, B. S., & Akour, A. A. (2022) · Molecules · doi:10.3390/molecules27217174 · Cited by 33
Cichoń, N., Bijak, M., Miller, E. D., Niwald, M., & Saluk, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/408745 · Cited by 33
Baker, G. B., Matveychuk, D., MacKenzie, E. M., Holt, A., Wang, Y., & Kar, S. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.03.003 · Cited by 33
Rahman, S. U., Ali, T., Hao, Q., He, K., Li, W., Ullah, N., Zhang, Z., Jiang, Y., & Li, S. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03396-w · Cited by 33
RetractedEvidence for neurotoxicity associated with amoxicillin in juvenile rats
Atlı, Ö., Özkay, Ü. D., Ilgın, S., Aydin, T., Akbulut, E. N., & Sener, E. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327115607948 · Cited by 35
Carbonyl stress and schizophrenia
Arai, M., Miyashita, M., Kobori, A., Toriumi, K., Horiuchi, Y., & Itokawa, M. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12216 · Cited by 32
Yang, M., & Lung, F. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2291-7 · Cited by 32
Unraveling the Serum Metabolomic Profile of Post-partum Depression
Papadopoulou, Z. L., Vlaikou, A., Theodoridou, D., Komini, C., Chalkiadaki, G., Vafeiadi, M., Margetaki, K., Trangas, T. T., Turck, C. W., Syrrou, M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00833 · Cited by 36
Langley, M. R., Ghaisas, S., Palanisamy, B. N., Ay, M., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113716 · Cited by 36
Dehghan, P., Nejati, M., Vahid, F., Almasi‐Hashiani, A., Saleh‐Ghadimi, S., Parsi, R., Vayghan, H. J., Shivappa, N., & Hébert, J. R. (2022) · BMC Public Health · doi:10.1186/s12889-022-13879-2 · Cited by 33
The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions
Weng, Y., Chien, T., Kuan, I., & Chern, Y. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0473-x · Cited by 32
Roedding, A. S., Tong, S. Y., Auyeung, W. T., Li, P. P., & Warsh, J. J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.04.025 · Cited by 31
Elevated plasma F2-isoprostane levels in schizophrenia
Lee, E., Eyler, L. T., Wolkowitz, O. M., Martin, A. S., Reuter, C., KRAEMER, H. C., & Jeste, D. V. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.011 · Cited by 31
Tobore, T. O. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24492 · Cited by 32
Sol, G. A. P., da Silva, A., Hermsdorff, H. H. M., Moreira, A. P. B., & de Aguiar, A. S. (2021) · Journal of Clinical and Translational Research · doi:10.18053/jctres.07.202105.005 · Cited by 31
Is There a Link between Oropharyngeal Microbiome and Schizophrenia? A Narrative Review
Martin, S., Foulon, A., El‐Hage, W., Dufour‐Rainfray, D., & Denis, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020846 · Cited by 31
Salahinejad, A., Attaran, A., Meuthen, D., Rachamalla, M., Chivers, D. P., & Niyogi, S. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.154794 · Cited by 31
Gazal, M., Ortmann, C. F., Martins, F. A., STRECK, E. L., Quevedo, J., de Campos, Á. M., Stefanello, F. M., Kaster, M. P., Ghisleni, G., Reginatto, F. H., et al. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.07.007 · Cited by 34
Trapp, G., Allen, K. L., Black, L. J., Ambrosini, G. L., Jacoby, P., Byrne, S. M., Martin, K., & Oddy, W. H. (2016) · Food Science & Nutrition · doi:10.1002/fsn3.355 · Cited by 31
Huang, X., Fan, Y., Han, X., Huang, Z., Yu, M., Zhang, Y., Xu, Q., Li, X., Wang, X., Lu, C., et al. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15061215 · Cited by 35
do Prado, C. H., Grassi-Oliveira, R., Wieck, A., Zaparte, A., Filho, L. D., da Silva Morrone, M., Moreira, J. C., & Bauer, M. E. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.062 · Cited by 28
Pipingas, A., Camfield, D., Stough, C. K. K., Cox, K., Fogg, E., Tiplady, B., Sarris, J. J., White, D., Sali, A., Wetherell, M. A., et al. (2013) · Appetite · doi:10.1016/j.appet.2013.05.016 · Cited by 30
Ding, L., Zhang, X., Guo, H., Yuan, J., Li, S., Hu, W., Golden, T. A., & Wu, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133405 · Cited by 30
Santos, P. C. D., Herrmann, A. P., Elisabetsky, E., & Piato, Â. (2018) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2018-0005 · Cited by 33
Larsen, E. L., Weimann, A., & Poulsen, H. E. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.030 · Cited by 30
Kambe, Y., & Miyata, A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.006 · Cited by 30
Relationship between oxidative stress and chronic daily headache in children
Vurucu, S., Karaoglu, A., Paksu, M., Yeşilyurt, Ö., Öz, O., Ünay, B., & Akın, R. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327112459204 · Cited by 30
The Association Among Bipolar Disorder, Mitochondrial Dysfunction, and Reactive Oxygen Species
Kageyama, Y., Okura, S., Sukigara, A., Matsunaga, A., Maekubo, K., Oue, T., Ishihara, K., Deguchi, Y., & Inoue, K. (2025) · Biomolecules · doi:10.3390/biom15030383 · Cited by 34
Immunochemical detection of oxidatively damaged DNA
Rössner, P., & Šrám, R. J. (2011) · Free Radical Research · doi:10.3109/10715762.2011.632415 · Cited by 29
Novel neuromuscular blocking drugs and antagonists
Heerdt, P. M., Sunaga, H., & Savarese, J. J. (2015) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000209 · Cited by 29
Liang, Z., Bai, S., Shen, P., Hu, Q., Wang, X., Dong, M.-X., Wang, W., Li, J., Cheng, K., Zhang, S., et al. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.001 · Cited by 29
Huang, M.-W., Lin, Y., Chang, C., Lei, F., Ho, E.-P., Liu, R.-S., Shyu, W., & Hsieh, C. (2018) · Theranostics · doi:10.7150/thno.25189 · Cited by 28
Entangled radicals may explain lithium effects on hyperactivity
Zadeh‐Haghighi, H., & Simon, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-91388-9 · Cited by 29
Anxiety, neuroticism and oxidative stress: Cross‐sectional study in non‐smoking college students
Matsushita, M., Kumano‐go, T., Suganuma, N., Adachi, H., Yamamura, S., Morishima, H., Shigedo, Y., Mikami, A., Takeda, M., & Sugita, Y. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02109.x · Cited by 31
Interactions of atenolol with alprazolam/escitalopram on anxiety, depression and oxidative stress
Shahzad, N., Ahmad, J., Khan, W., Alghamdi, S., Ain, M. R., Ibrahim, I. A. A., Akhtar, M., & Khanam, R. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.12.015 · Cited by 29
Khalifeh, S., Oryan, S., Digaleh, H., Shaerzadeh, F., Khodagholi, F., Maghsoudi, N., & Zarrindast, M. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0370-z · Cited by 29
Jalsrai, A., Numakawa, T., Kunugi, H., Dieterich, D. C., & Becker, A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.065 · Cited by 29
Upstream Pathways Controlling Mitochondrial Function in Major Psychosis
Machado, A. K., Pan, A. Y., da Silva, T. M., Duong, A., & Andreazza, A. C. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716648297 · Cited by 30
Abuelezz, S. A., & Hendawy, N. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000335 · Cited by 28
Deslauriers, J., Racine, W., Sarret, P., & Grignon, S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.061 · Cited by 29
Oxidative status and prolidase activities in generalized anxiety disorder
Ercan, A. C., Bahçeci, B., Polat, S., Cenker, O. C., Bahçeci, İ., Köroğlu, A., Şahin, K., & Hocaoğlu, Ç. (2016) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2016.10.008 · Cited by 28
Lima, E. B. C., de Sousa, C. N. S., Vasconcelos, G. S., Meneses, L. N., Pereira, Y. F. E. S., Ximenes, N. C., Júnior, M. A. S., Matos, N. C. B., Brito, R., Miron, D., et al. (2016) · Journal of Natural Medicines · doi:10.1007/s11418-016-0970-8 · Cited by 27
Anxiolytic and anti-stress effects of acute administration of acetyl-L-carnitine in zebrafish
Pancotto, L., Mocelin, R., Marcon, M., Herrmann, A. P., & Piato, Â. (2018) · PeerJ · doi:10.7717/peerj.5309 · Cited by 27
Radical pairs can explain magnetic field and lithium effects on the circadian clock
Zadeh‐Haghighi, H., & Simon, C. (2022) · Scientific Reports · doi:10.1038/s41598-021-04334-0 · Cited by 31
Richardson, A. C., Heath, A. M., Haszard, J. J., Polak, M., Houghton, L. A., & Conner, T. S. (2015) · Nutrients · doi:10.3390/nu7085270 · Cited by 27
de Araújo, F. Y. R., de Oliveira, G. V., Gomes, P. X. L., Soares, M. A., Silva, M. I. G., Carvalho, A. F., de Moraes, M. O., de Moraes, M. E. A., Vasconcelos, S. M. M., Viana, G. S. D. B., et al. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01312.x · Cited by 27
Tempol Treatment Reduces Anxiety-Like Behaviors Induced by Multiple Anxiogenic Drugs in Rats
Patki, G., Salvi, A., Liu, H., Atrooz, F., Alkadhi, I., Kelly, M., & Salim, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117498 · Cited by 27
RetractedSamuelsson, M., Skogh, E., Lundberg, K., Vrethem, M., & Öllinger, K. M. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.09.014 · Cited by 27
Kartalcı, Ş., Karabulut, A. B., Özcan, C., Porgalı, E., & Ünal, S. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.05.007 · Cited by 27
Low Serum Levels of Uric Acid are Associated With Development of Poststroke Depression
Gu, Y.-Y., Han, B., Wang, L.-P., Chang, Y., Zhu, L., Ren, W.-W., Yan, M., Zhang, X., & He, J.-C. (2015) · Medicine · doi:10.1097/md.0000000000001897 · Cited by 25
Gazal, M., Kaufmann, F. N., Acosta, B. A., Oliveira, P. S., Valente, M. R., Ortmann, C. F., Sturbelle, R. T., Lencina, C. L., Stefanello, F. M., Kaster, M. P., et al. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1610-5 · Cited by 28
An empirical review on oxidative stress markers and their relevance in obsessive-compulsive disorder
Kar, S., & Choudhury, I. (2016) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/2231-0738.191641 · Cited by 26
Potential drug targets and treatment of schizophrenia
Kumar, A., Yadav, M., Parle, M., Dhingra, S., & Dhull, D. K. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0340-5 · Cited by 26
Zhu, C., Li, H., Kong, X., Wang, Y., Sun, T., & Wang, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.819470 · Cited by 26
Ying, J., Chew, Q. H., McIntyre, R. S., & Sim, K. (2023) · Genes · doi:10.3390/genes14030689 · Cited by 29
Hossen, S. M. M., Tanim, M. A. H., Hossain, M. S., Sami, S. A., & Emon, N. U. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.07.016 · Cited by 25
In vitro S100B secretion is reduced by apomorphine: Effects of antipsychotics and antioxidants
Nardin, P., Tramontina, A. C., Quincozes‐Santos, A., Tortorelli, L. S., Lunardi, P. S., Klein, P. R., Wartchow, K. M., Bobermin, L. D., Gottfried, C., Elisabetsky, E., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.04.004 · Cited by 26
Singapura, N., & Kandangath, R. (2013) · Journal of Biomedical Research · doi:10.7555/jbr.27.20120059 · Cited by 26
Barzilay, R., Ben‐Zur, T., Sadan, O., Bren, Z., Taler, M., Lev, N., Tarasenko, I., Gueta, R. U., Gil‐Ad, I., Melamed, E., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.64 · Cited by 26
Ross, B. M., Maxwell, R., & Glen, I. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.032 · Cited by 26
Cysteine Reversal of the Novel Neuromuscular Blocking Drug CW002 in Dogs
Sunaga, H., Malhotra, J. K., Yoon, E. J., Savarese, J. J., & Heerdt, P. M. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181d31f8c · Cited by 26
Mehta, D., Iwamoto, K., Ueda, J., Bundo, M., Adati, N., Kojima, T., & Kato, T. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.10.009 · Cited by 26
Piubelli, C., Vighini, M., Mathé, A. A., Domenici, E., & Carboni, L. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001318 · Cited by 26
Miljević, Č., Nikolić‐Kokić, A., Nikolic, M. R., Niketić, V., Spasić, M. B., Lečić‐Toševski, D., & Blagojević, D. P. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2272 · Cited by 26
Kartalcı, Ş., Karabulut, A. B., Erbay, L. G., & Acar, C. (2016) · Journal of Ect · doi:10.1097/yct.0000000000000303 · Cited by 26
Vieira, G. D. L. T., Lossie, A. C., Lay, D. C., Jr., Radcliffe, J. S., & Garner, J. P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175222 · Cited by 26
Metadata
- Authors
- Ng, F., Berk, M., Dean, O., & Bush, A. I.
- Affiliations
- Barwon Health (AU)
- Mental Health Research Institute (AU)
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-21
- Volume
- 11
- Issue
- 06
- Pages
- 851-76
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W1986211748
- Cited by
- 1,069
- References
- 203
- Citations by year
- 2026: 23 · 2025: 52 · 2024: 49 · 2023: 60 · 2022: 52 · 2021: 81 · 2020: 73 · 2019: 69 · 2018: 74 · 2017: 42 · 2016: 84 · 2015: 71 · 2014: 74 · 2013: 68 · 2012: 50
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Deakin Research Online (Deakin University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- oxidative stress, mental illness, schizophrenia, bipolar disorder, depression, anxiety disorders, cocaine dependence, autism spectrum disorder, attention deficit hyperactivity disorder, antioxidants, N-acetylcysteine, oxidative stress biomarkers, psychopharmacology, common pathogenic mechanisms
- MeSH terms
- Antioxidants, Mental Disorders, Humans, Databases, Bibliographic, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review